1. Home
  2. DJT vs NBTX Comparison

DJT vs NBTX Comparison

Compare DJT & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Trump Media & Technology Group Corp.

DJT

Trump Media & Technology Group Corp.

N/A

Current Price

$9.14

Market Cap

2.1B

Sector

Technology

ML Signal

N/A

Logo Nanobiotix S.A.

NBTX

Nanobiotix S.A.

N/A

Current Price

$39.28

Market Cap

2.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DJT
NBTX
Founded
2021
2003
Country
United States
France
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.3B
IPO Year
2021
2018

Fundamental Metrics

Financial Performance
Metric
DJT
NBTX
Price
$9.14
$39.28
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$36.00
AVG Volume (30 Days)
3.8M
153.6K
Earning Date
05-08-2026
03-31-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,682,600.00
N/A
Revenue This Year
N/A
$58.17
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
1.76
N/A
52 Week Low
$6.96
$8.41
52 Week High
$17.97
$57.14

Technical Indicators

Market Signals
Indicator
DJT
NBTX
Relative Strength Index (RSI) 54.48 48.30
Support Level $7.95 $36.98
Resistance Level $9.94 $41.06
Average True Range (ATR) 0.43 2.95
MACD 0.05 -0.29
Stochastic Oscillator 68.88 15.87

Price Performance

Historical Comparison
DJT
NBTX

About DJT Trump Media & Technology Group Corp.

Trump Media & Technology Group Corp is a media and technology company rooted in social media, digital streaming, information technology infrastructure, and more. Its initial product launch will focus on its social media platform, Truth Social, which encourages an open, free, and honest conversation without discriminating against political ideology.

About NBTX Nanobiotix S.A.

Nanobiotix SA is a late-stage clinical biotechnology company focused on re-inventing medicine by building new therapies atom by atom, developing widely applicable, first-in-class, physics-based nanotherapeutics to transform treatment outcomes and expand life for millions of patients. The objective of this physics-based approach is to allow nanoparticles to be combined with other drugs or therapeutic modalities and to integrate seamlessly into clinical practice without adding burden for the patient, healthcare provider, or healthcare system. It has three platforms Nanoradioenhancer platform: Nanoprimer platform: and Neurological disease platform. It has one segment, which is the research and development of product candidates that use proprietary nanotechnology to transform cancer treatment.

Share on Social Networks: